To estimate the CSF MTBR-tau biomarker performance in clinically diagnosed primary tauopathies, we measured CSF MTBR-tau275/t-tau in an additional independent cohort of 238 primary tauopathies with single LP (Extended Data Fig. 2). This evidence concerns the gene MAPT and tauopathy.